Insulin therapy in critically ill patients

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 7, Issue 2, 2004, Pages 199-205

  Solano, Thomas ^a   Totaro, Richard ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Apoptosis; GIK infusion; Insulin; Normoglycaemia

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; FATTY ACID; GLUCOSE; GLYCOGEN; INSULIN; POTASSIUM; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT; VERAPAMIL; ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; APOPTOSIS; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; CLINICAL PROTOCOL; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CRITICAL ILLNESS; DRUG MECHANISM; DRUG OVERDOSE; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE UNIT; META ANALYSIS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; SIDE EFFECT; STRESS ECHOCARDIOGRAPHY; TREATMENT OUTCOME; ANIMAL; HEART INFARCTION; HYPERGLYCEMIA; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; CRITICAL CARE; CRITICAL ILLNESS; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; MYOCARDIAL INFARCTION; POTASSIUM; TREATMENT OUTCOME;

EID: 3042596029     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200403000-00015     Document Type: Review

References (40)

1. McCowan KC, Malhotra A, Bistrian BR. Endocrine and metabolic dysfunction syndromes in the critically ill. Crit Care Clin 2001; 1:107-124
2. Fietsam R Jr, Basset J, Glover JL. Complications of coronary artey bypass surgery in diabetic patients. Am Surg 1996; 57:551-557.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
4. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367.
5. Sonntag S, Opitz CX, Wellnhofer E, et al. Effects of calcium sensitizer levosimendan on stunned myocardium after percutaneous transluminal coronary angioplasty. Eur Heart J 2000; 21 (Suppl.):40.1
6. Sodi-Pallares D, Testelli MR, Fishleder BL, et al. Effects of an intravenous infusion of a potassium-insulin-glucose solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 1962; 9:166-181
7. Opie LH. The glucose hypothesis: relation to acute myocardial ischemia. J Mol Cell Cardiol 1970; 1:107-114.
8. Stanley AW Jr, Moraski RE, Russell RO, et al. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. Am J Cardiol 1975; 36:929-937.
9. Oliver MF. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994; 343:155-158.
10. Angelos MG, Murray HN, Gorsline RT, Klawitter KF. Glucose, insulin and potassium (GIK) during reperfusion mediates improved myocardial energetics. Resuscitation 2002; 55:329-336.
11. Depre C, Vanoverschelde JLJ, Taegtmeyer H. Glucose for the heart. Circulation 1999; 99:578-588.
12. Cave AC, Ingwall JS, Friedrich J, et al. ATP synthesis during low-flow ischaemia. Influence of increased glycolytic substrate. Circulation 2000; 101:2090-2096.
13. Milavetz JJ, Giebel DW, Christian TF, et al. Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol 1998; 31:1246-1251.
14. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell survival signaling. Circ Res 2001; 89:1191-1198.
15. Das UN. Newer uses of glucose-insulin-potassium regimen. Med Sci Monit 2000; 6:1053-1055.
16. Aikawa R, Nawano M, Gu Y, Katagiri H. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 2000; 102:2873-2879.
17. ATP channels in the isolated rabbit heart. Bas Res Cardiol 1999; 94:188-198.
18. Davi G, Averna M, Catalano I, et al. Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control. Diabet Res 1989; 10:7-12.
19. Diaz-Araya G, Nettle D, Castro P, et al. Oxidative stress after reperfusion with primary coronary angioplasty: lack of effect of glucose-insulin-potassium infusion. Crit Care Med 2002; 30:417-422.
20. Medical Research Council, Working Party on the Treatment of Myocardial Infarction. Potassium, glucose, and insulin treatment for acute myocardial infarction. Lancet 1968; 2:1355-1360.
21. Sack MN, Yellon DM. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia. J Am Coll Cardiol 2003; 41:1404-1407. A concise summary of the effects of insulin on cell survival.
22. Lazar HL, Zhang X, Rivers S, et al. Limiting ischaemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg 1995; 60:411-416.
23. Zhu P, Lu L, Xu Y, et al. Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 2000; 278:H595-H603.
24. Ramanathan T, Shirota K, Monta S, et al. Glucose-insulin-potassium solution improves left ventricular mechanics in diabetes. Ann Thorac Surg 2002; 73:582-587.
25. Kerns W, Schroeder D, Willaims C, et al. Insulin improves survival in a canine model of acute beta blockade toxicity. Ann Emerg Med 1997; 29:748-757.
26. Kline JA, Leonova E, Raymond RM. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med 1995; 23:1251-1263.
27. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction. An overview of randomized placebo-controlled trials. Circulation 1997; 96:1152-1156.
28. Malmberg K, Ryden L, Efendic S, et al. Randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26:57-65.
29. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Long term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study. Circulation 1999; 99:2626-2632.
30. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction. The ECLA Glucose-Insulin-Potassium Trial. Circulation 1998; 98:2227-2234. Online (http://www.ecla.org.ar)
31. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin- potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drug Ther 1999; 13:191-200.
32. Yetkin E, Senen K, Ileri M, et al. Comparison of low dose dobutamine stress echocardiography and echocardiography during glucose-insulin-potassium infusion for detection of myocardial viability after anterior myocardial infarction. Coron Artery Dis 2002; 13:145-149.
33. Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery: controversies and possible solutions. Ann Thorac Surg 2003; 75 (suppl):S721-S728. An excellent review of the current status of GIK infusions in the cardiac surgical population.
34. Lell WA, Nielson VG, McGiffin DC, et al. Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg 2002; 73:1246-1252.
35. Lazar HL. Invited commentary. Ann Thorac Surg 2002; 73:1252-1253.
36. Besogul Y, Tunerir B, Asian R, et al. Clinical, biochemical and histochemical assessment of pretreatment with glucose-insulin-potassium for patients undergoing mitral valve replacement in the third and fourth functional groups of the New York Heart Association. Cardiovasc Surg 1999; 7:645-650.
37. Rao V, Christakis GT, Weisel RD, et al. The Insulin Cardioplegia Trial: myocardial protection for urgent coronary bypass grafting. J Thorac Cardiovasc Surg 2002; 123:928-935.
38. Lazar HL. The Insulin Cardioplegia Trial. J Thorac Cardiovasc Surg 2002; 123:842-844.
39. Khoury VK, Haluska B, Prins J, Marwick TH. Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction. Heart 2003; 89:61-65.
40. Bertolini G, Latronico N, Brazzi L, et al. Insulin dose or glycemic control for the critically ill? Crit Care Med 2003; 31:2565-2566. An analysis of the previous work to determine the relative importance of insulin dose or glycaemic control.